Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol-Reference-Cited by-同舟云学术

Genomic alterations and radioresistance in breast cancer: an analysis of the ProfiLER protocol

Published:2017-11 Issue:11 Volume:28 Page:2773-2779
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bernichon E.,Vallard A.,Wang Q.,Attignon V.,Pissaloux D.,Bachelot T.,Heudel P.E.,Ray-Coquard I.,Bonnet E.,de la Fouchardière A.,Faure C.,Chopin N.,Beurrier F.,Racadot S.,Sunyach M.P.,Rancoule C.,Perol D.,Corset V.,Agrapart V.,Tinquaut F.,Blay J.-Y.^ORCID,Magné N.,Trédan O.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/11/2773/21556175/mdx488.pdf

Reference21 articles.

1. Selecting breast cancer patients with T1–T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy;Truong;Int J Radiat Oncol Biol Phys,2005

2. Targeting a cornerstone of radiation resistance: cancer stem cell;Moncharmont;Cancer Lett,2012

3. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials;McGale;Lancet,2014

4. Comprehensive molecular portraits of human breast tumours;Cancer Genome Atlas Network;Nature,2012

5. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?;Sotiriou;Nat Rev Cancer,2007

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic profiling in radiotherapy: a comprehensive review;Frontiers in Oncology;2024-07-26

2. Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literature;The Breast;2023-12

3. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy;Acta Biomaterialia;2023-10

4. Sorafenib in Molecularly Selected Cancer Patients: Final Analysis of the MOST-Plus Sorafenib Cohort;Cancers;2023-06-30

5. New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine;Veterinary and Comparative Oncology;2023-06-12